Broadfin Capital »

STAAR Surgical Company shares owned by Broadfin Capital

Quarter-by-quarter ownership of STAAR Surgical Company (STAA) shares owned by Broadfin Capital from 13F filings

Historical chart of Broadfin Capital investment in STAAR Surgical Company

Tip: Access up to 7 years of quarterly data

All positions including STAAR Surgical Company held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in STAAR Surgical Company by Broadfin Capital

Quarter filed Position value Share count Share price at filing
2019-12-31 $16M 462k 35.17

More positions owned by Broadfin Capital

Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Biohaven Pharmaceutical Holding
SPDR S&P Biotech (XBI)
BioDelivery Sciences International
Alkermes (ALKS)
Viewray (VRAYQ)
Amarin Corporation (AMRN)
Quotient
Eiger Biopharmaceuticals
STAAR Surgical Company (STAA)
Intersect Ent
Progenics Pharmaceuticals
Nanostring Technologies (NSTGQ)
Iovance Biotherapeutics (IOVA)

View all positions for Broadfin Capital

Top funds holding STAAR Surgical Company

Vanguard Group
Baillie Gifford & Co
Palo Alto Investors
Defender Capital
Geneva Capital Management
Voloridge Investment Management
Anatole Investment Management
Yunqi Capital
Citadel Advisors
Millennium Management
Norges Bank Investment Management
Charles Schwab Investment Management
Royal Bank of Canada
Bank of New York Mellon
Bank of America Corporation

View all funds holding STAAR Surgical Company